መነሻ › Multiple Myeloma › North Carolina › Durham
በDurham፣ NC ለMultiple Myeloma የሚደረጉ ክሊኒካዊ ጥናቶች
ለMultiple Myeloma የሚደረጉ 37 ጥናቶች በDurham እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Chapel Hill · 10 ማይል ርቀት
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Duke University Medical Center, Durham
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke University Medical Center, Durham
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Durham VAMC, Durham
- University of North Carolina, Chapel Hill · 10 ማይል ርቀት
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Durham VAMC, Durham
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- University of North Carolina at Chapel Hill /ID# 277708, Chapel Hill · 10 ማይል ርቀት
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Duke University, Durham
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of North Carolina Medical Center, Chapel Hill · 10 ማይል ርቀት
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of North Carolina at Chapel Hill /ID# 272454, Chapel Hill · 10 ማይል ርቀት
HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke University Health System, Durham
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13 ማይል ርቀት
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- GSK Investigational Site, Chapel Hill · 10 ማይል ርቀት
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Duke University Hospital, Durham
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Durham
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Durham
- Research Site, Chapel Hill · 10 ማይል ርቀት
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
ተሳታዮችን በመፈለግ ላይ
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 ማይል ርቀት
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Duke Cancer Center, Durham
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UNC Hospitals Adult Oncology Clinics, Chapel Hill · 10 ማይል ርቀት
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of North Carolina at Chapel Hill /ID# 274667, Chapel Hill · 10 ማይል ርቀት
Selinexor and Backbone Treatments of Multiple Myeloma Patients
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke Institute of Cancer/ Duke University, Durham
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of North Carolina /ID# 251203, Chapel Hill · 10 ማይል ርቀት
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of North Carolina (Data Collection Only), Chapel Hill · 10 ማይል ርቀት
Registry of Older Patients With Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 ማይል ርቀት
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Duke University, Durham
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of North Carolina, Chapel Hill · 10 ማይል ርቀት
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke Comprehensive Cancer Center, Durham
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of North Carolina Hospitals at Hillsborough, Chapel Hill · 10 ማይል ርቀት
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke University Health System (DUHS), Durham
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University Of North Carolina Health Care - Hillsborough Campus /ID# 278230, Hillsborough · 13 ማይል ርቀት
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of North Carolina, Chapel Hill · 10 ማይል ርቀት
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of North Carolina, Chapel Hill · 10 ማይል ርቀት
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke University, Durham
- UNC Hospital, Chapel Hill · 10 ማይል ርቀት
Registry for Adults With Plasma Cell Disorders (PCD's)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- North Carolina Cancer Hospital, Chapel Hill · 10 ማይል ርቀት
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 ማይል ርቀት
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Duke University Health System (DUHS), Durham
በሌሎች ከተሞች ለMultiple Myeloma የሚደረጉ ጥናቶች
- New York City, NY60 ጥናቶች
- Boston, MA42 ጥናቶች
- Atlanta, GA41 ጥናቶች
- Houston, TX38 ጥናቶች
- Nashville, TN32 ጥናቶች
- Denver, CO27 ጥናቶች
- Rochester, MN24 ጥናቶች
- St. Louis, MO24 ጥናቶች
- Columbus, OH24 ጥናቶች
- Baldwin Park, CA23 ጥናቶች
- Chicago, IL22 ጥናቶች
- Seattle, WA22 ጥናቶች
በDurham ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር63 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)58 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር39 ጥናቶች
- Metastatic Cancer33 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ33 ጥናቶች
- የሳንባ ካንሰር32 ጥናቶች
- የፕሮስቴት ካንሰር32 ጥናቶች
- የኮሎሬክታል ካንሰር28 ጥናቶች
- ክሮኒክ ሊምፎሳይቲክ ሉኬሚያ27 ጥናቶች
- የእንቁላል ካንሰር27 ጥናቶች
- የልብ ድካም26 ጥናቶች
- የፓንክሪያስ ካንሰር24 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።